KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) EBIT (2016 - 2025)

Zoetis (ZTS) has disclosed EBIT for 14 consecutive years, with $841.0 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 4.86% to $841.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2025, up 6.16% year-over-year, with the annual reading at $3.7 billion for FY2025, 5.33% up from the prior year.
  • EBIT for Q4 2025 was $841.0 million at Zoetis, down from $964.0 million in the prior quarter.
  • The five-year high for EBIT was $1.0 billion in Q2 2025, with the low at -$131.0 million in Q1 2021.
  • Average EBIT over 5 years is $772.3 million, with a median of $811.0 million recorded in 2023.
  • The sharpest move saw EBIT soared 735.9% in 2021, then decreased 10.14% in 2023.
  • Over 5 years, EBIT stood at $642.0 million in 2021, then grew by 13.4% to $728.0 million in 2022, then rose by 1.37% to $738.0 million in 2023, then grew by 8.67% to $802.0 million in 2024, then increased by 4.86% to $841.0 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at $841.0 million, $964.0 million, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.